Scholars Central

Short communicationPublished 25 Mar 2022

Research on an HIV vaccine: The Difficulties and the Possibilities

Authors: Govind Gunakamadeva

HIV: Current Research

Volume 7 · Issue 1 · Pages 1

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

HIV infection, which was once terminally ill, is now a chronic disease with a longer lifespan thanks to ongoing diagnostic and treatment advancements. Initially, these advantages were only available to patients in Resource-Rich Countries (RRCs), there has been a global movement to give millions of HIV-infected people in Resource-Limited Countries (RLCs) access to antiretrovirals . Most committed individuals receiving the most recent Combination Antiretroviral Therapy (cART) achieve viral suppression. While assays that look for latent tissue reservoirs with integrated viral DNA have revealed new information about treatment objectives, the cause of viral rebound when treatment is administered, and continued low-level viremia in patients who appear to be "suppressed," viral load tests with greater sensitivity have improved our understanding of these two factors.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in HIV: Current Research.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalHIV: Current Research
  • SubjectInfectious Diseases
  • BylineArticles whose byline prints “Govind Gunakamadeva”